HTID#4 Agenda

Thursday, October 13th 2022

08:00am - 8:55am (CET)

Opening ceremony

• Maryvonne Hiance President at HealthTech For Care
• Andrzej Rys Principal Scientific Adviser, Directorate-General for Health and Food Savety at the European Commission
• Roland Lescure French Minister Delegate to the Minister of the Economy, Finance and Industrial and Digital Sovereignty, in charge of Industry

Keynote : Europe needs dynamic and resilient ecosystems, provider of innovative solutions and growth financing’

• Pierre Courteille Chief Commercial Officer & Vice President Business Development at ABIVAX
• Marc Dechamps President at CEBR

09:00am - 9:50am

Build tomorrow’s healthcare for all European citizen

• Christian Pierret Former Minister of Industry (moderator)
• Daniel Cohen Medical Geneticist, Co founder of Genethon and serial entrepreneur
• Michel Goldman President I3h Institute at the Free University of Brussels and Former Executive Director of the European Medicines Initiative
• Felicitas Riedl Director of the Innovation and Competitiveness Department - Projects Directorate at the European Investment Bank

09:50am - 10:05am

10:05am - 10:55am

Funding Innovation: is there a creative approach smarter than pouring money?

• Philippe Lopes-Fernandes Executive Vice President, Chief Business Officer at Ipsen (moderator)
• Laurent Arthaud Managing Director for Investments in Lifesciences, Ecotechnologies and French Tech at Bpifrance
• Iordanis Arzimanoglou Programme Manager for Health and Biotechnology, at European Innovation Council, European Commission
• Jean-Marc Bourez CEO ad interim at EIT Health, Managing Director EIT Health France
• Enric Claverol-Tinturé Programme Manager for Medical Technologies and Medical Devices, at European Innovation Council, European Commission
• Johanna Michielin Head at Biolabs France

11:00am - 12:10pm

Age-related diseases, a continuum from birth to death

• Antoni Montserrat Vice President at the Luxembourg National Committee for rare diseases (moderator)
• André Baruchel Professor of Paediatrics - Head of Department at APHP, University of Paris
• Ross Jeggo Global Head of R&D Neuroscience and Immuno-inflammation at Servier
• Walid Kamoun Global Head of R&D Oncology at Servier
• Ana Limon SVP Clinical Development & GMA. at Oryzon Genomics
• Gary Waanders Head of Investor Relations and Communications at AC Immune

12:10pm - 01:20pm

01:20pm - 01:40pm

How collaboration between pharmaceutical and biotech companies may unleash the full potential of cell therapy?

• Luigi Ravagnan Executive Director & Worldwide Strategic Collaborations, Global Medical Affairs at Bristol Myers Squibb (moderator)
• Michael Lanero Fidalgo COO at Treefrog Therapeutics
• Shivani Srivastava Vice President, Cell Therapy Development at Bristol Myers Squibb

01:45pm - 02:25pm

A vision of the future: European health systems transformations in 2032

• Anca Petre HealthTech & Web3 Speaker & Consultant, co-Founder at 23 Consulting (moderator)
• Emmanuel Bacry Chief Scientific Officer at Health Data Hub
• Christophe Cosio Value, Access and Policy Executive Director at Amgen France
• Antoine Gizardin Principal at Roland Berger
• Louisa Stüwe Project director at Ministerial Digital Health delegation of French Ministry of Health & Prevention
• Isabelle Zablit Digital Health Europe & International Director at French Ministry of Health & Prevention

02:30pm - 03:25pm

Covid wake up call on health innovation investments - Opportunities and turbulence

• Cédric Moreau Partner at Sofinnova Partners (moderator)
• Elena Coluccelli-Guérin Managing Partner, Healthcare M&A, focus on mid cap at Rothschild & Co
• Aniz Girach Ophthalmologist, Board Director, Chief Medical Officer at ProQR Therapeutics
• Yann Le Flohic Deputy Chairman of the Board at Life Sciences Acceleration Alliance, Co-founder at Allison+Partners PR France

03:25pm - 03:50pm

03:50pm - 04:10pm

Particularities of investing in digital health

• Sophie Pelé Lawyer and Partner at Dechert LLP
• Simon Turner Partner at Sofinnova Partners

04:15pm - 05:10pm

How AI is revolutionizing the patient-doctor relationship

• Emmanuelle Trombe Lawyer and Partner at McDermott Will & Emery (moderator)
• Patrick Boisseau Director General, Strategic Initiatives at MedTech Europe
• Koen Cobbaert Senior Manager - Quality, Standards & Regulations at Philips
• Clara Moschetti Partnership and Project Manager at AI for Health by Startup Inside
• Katja Niedermeier Specialist in general medicine, diabetologist at Praxis
• Andrea Touppen Nutrional scientist - Type 1 diabetic patient

05:15pm - 06:15pm

Translational microbiome medicine to treat serious oncology and infectious diseases

• Isabelle de Cremoux CEO and Managing Partner at Seventure Partners (moderator)
• Hervé Affagard Founder and CEO at MaaT Pharma
• Carl Bilbo Senior Vice President, Microbiome Franchise at Ferring Pharmaceuticals
• Mohamad Mohty Professor of Hematology at Sorbonne University, and head of the Clinical Hematology and Cellular Therapy Department at Saint-Antoine Hospital
• Tim Sharpington COO at Microbiotica
• Hassane Zarour Professor of Medicine, Immunology and Dermatology, University of Pittsburgh

06:15pm - 06:30pm

06:30pm - 06:45pm

People at the heart of Life Science Investing: in conversation with Sabine Dandiguian, Managing Partner, Jeito Capital

• Sabine Dandiguian Managing Partner at Jeito

06:50pm - 07:30pm

Special Guest

• Hubert Gambs Deputy Director-General at DG GROW, Internal Market, Industry, Entrepreneurship and SMEs at European Commission

07:30pm - 10:00pm

Friday, October 14th 2022

08:15am - 08:50am (CET)

In vitro diagnostics industry in Europe : at the heart of patient’s care

• Gérald Ulrich CEO of Quantamatrix Europe (moderator)
• Marie Anson Project Manager biomarkers and biomanufacturing at EIT Health
• Ludovic Bal General Manager France at LumiraDx
• Michel Lainé Marketing Director Infectious Diseases at Bio-Rad Laboratories

08:55am - 09:35am

Being Listed: Challenges and Opportunities

• Dominique Costantini Chairman and Director development at OSE Immunotherapeutics
• Michael Kloss CEO and Co-founder at eureKING
• Guillaume Morelli Head of SMEs France at Euronext
• Jean Luc Vandebroek Chief Financial Officer, IR and Communication at Hyloris Pharmaceuticals

09:40am - 10:05am

10:05am - 10:55am

Matching the required talents for a sustainable development: constraints and opportunities!

• Frederik Alberchtsen Consultant at Russell Reynolds Associates (moderator)
• Claude Bertrand Executive Vice President R&D at Servier
• Elsy Boglioli Hofman Founder and CEO at Bio-Up
• Marie Daniel General Secretary at TreeFrog Therapeutics
• Bernard Gilly CEO at GenSight Biologics
• Vanessa Malier Managing Partner at Kurma Partners

11:00am - 11:55am

Impact of mRNA application in innovative drugs with the support of adapted manufacturing settings (In the memory of François Gros)

• Philippe Kourilsky Professor Emeritus at Collège de France (moderator)
• Bruno Poddevin SVP Business & Corporate Development at DNA Script
• Regis Gervier Global Head, mRNA Center of Excellence at Sanofi
• Marcel Hollenstein Group leader at Pasteur Institute
• Christoph Huber Professor emeritus hematology-oncology Johannes-Gutenberg-University, co-founder BioNTech SE and TRON gGmbH

11:55am - 01:00pm

01:00pm - 01:55pm

Closing the gap in Women's Health : we need to be the change

• Elsy Boglioli Hofman Founder and CEO at Bio-Up (moderator)
• Bianca Coulter CEO at Coulter Partners
• Gonzague Issenmann Executive Chairman and CEO at Womed
• Marieta Jiménez Senior Vice President Europe at Merck Healthcare
• Jenny Yip Managing Partner at Adjuvant Capital
• Marcel van Duin VP, Head of External Innovation & Emerging Science at Organon

02:00pm - 02:55pm

Digital innovation tools empowering patients in collaboration with healthtech, pharma and investors

• Erik Tambuyzer Innovator in healthcare (moderator)
• Uroš Bogdanović Attorney at law at ANDRIĆ Attorneys-at-law, IDF Young Leader in Diabetes
• Alain Herrera Oncologist at Alain Oncologie Consulting and Hematologist at Antoine Béclère Hospital
• Anaïs Le Corvec Co-Founder at Cliclab Transformative Agent
• Christian Policard Founder at BDC
• Marion Soto VP Business Development at Ariana Pharma
• Jenny Yip Managing Partner at Adjuvant Capital

02:55pm - 03:05pm

03:05pm - 03:45pm

Social impact of an effective North Atlantic Bridge for long-term innovation

• Pierre Courteille CCO & VP Business Development at Abivax (moderator)
• Gabriela Apiou Strategic Alliances Director at Massachusetts General Hospital, Harvard Medical School
• Patrick Apiou Philosophy and Social Sciences Highschool Faculty at International School of Boston
• Florian Eichler Director of Center for Rare Neurological Diseases at Massachusetts General Hospital, Harvard Medical School

03:50pm - 04:30pm

04:30pm - 06:00pm